Your search returned 12 results.

Results
	1.	Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective. [electronic resource] by Goeree, Ron Chiva-Razavi, Sima Gunda, Praveen Jain, Minal Jugl, Steffen M Producer: 20190412 In: Journal of medical economics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative. [electronic resource] by Colombo, Giorgio L Di Matteo, Sergio Martinotti, Chiara Jugl, Steffen M Gunda, Praveen Naclerio, Mariantonietta Bruno, Giacomo M Publication details: ClinicoEconomics and outcomes research : CEOR 2018 In: ClinicoEconomics and outcomes research : CEOR vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison. [electronic resource] by Mease, Philip Choy, Ernest Nash, Peter Kalyvas, Chrysostomos Hunger, Matthias Pricop, Luminita Gandhi, Kunal K Jugl, Steffen M Thom, Howard Publication details: European journal of rheumatology 07 2019 In: European journal of rheumatology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison. [electronic resource] by Nash, Peter McInnes, Iain B Mease, Philip J Thom, Howard Hunger, Matthias Karabis, Andreas Gandhi, Kunal Mpofu, Shephard Jugl, Steffen M Publication details: Rheumatology and therapy 12 2018 In: Rheumatology and therapy vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study. [electronic resource] by Deodhar, Atul Conaghan, Philip G Kvien, Tore K Strand, Vibeke Sherif, Bintu Porter, Brian Jugl, Steffen M Gandhi, Kunal K Producer: 20190516 In: Clinical and experimental rheumatology vol. 37 Availability: No items available. Save to lists Add to cart (remove)
	6.	Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective. [electronic resource] by Goeree, Ron Chiva-Razavi, Sima Gunda, Praveen Graham, Christopher N Miles, LaStella Nikoglou, Efthalia Jugl, Steffen M Gladman, Dafna D Producer: 20180824 In: Journal of medical economics vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis. [electronic resource] by McInnes, Iain B Nash, Peter Ritchlin, Christopher Choy, Ernest H Kanters, Steve Thom, Howard Gandhi, Kunal Pricop, Luminita Jugl, Steffen M Producer: 20190919 In: Journal of comparative effectiveness research vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison. [electronic resource] by Nash, Peter McInnes, Iain B Mease, Philip J Thom, Howard Hunger, Matthias Karabis, Andreas Gandhi, Kunal Mpofu, Shephard Jugl, Steffen M Publication details: Rheumatology and therapy Jun 2018 In: Rheumatology and therapy vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. [electronic resource] by Krüger, Klaus von Hinüber, Ulrich Meier, Florian Tian, Haijun Böhm, Katharina Jugl, Steffen M Borchert, Kathrin Meise, Dominic König, Christine Braun, Sebastian Producer: 20191001 In: Rheumatology international vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison. [electronic resource] by Maksymowych, Walter P Strand, Vibeke Nash, Peter Yazici, Yusuf Thom, Howard Hunger, Matthias Kalyvas, Chrysostomos Gandhi, Kunal K Porter, Brian Jugl, Steffen M Publication details: European journal of rheumatology Dec 2018 In: European journal of rheumatology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study. [electronic resource] by Coates, Laura C Mease, Philip J Gossec, Laure Kirkham, Bruce Sherif, Bintu Gaillez, Corine Mpofu, Shephard Jugl, Steffen M Karyekar, Chetan Gandhi, Kunal K Producer: 20190712 In: Arthritis care & research vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study. [electronic resource] by McInnes, Iain B Mease, Philip J Schett, Georg Kirkham, Bruce Strand, Vibeke Williams, Nicole Fox, Todd Pricop, Luminita Jugl, Steffen M Gandhi, Kunal K Producer: 20190415 In: Arthritis research & therapy vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)